An effective vaccine is needed to halt the spread of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) pandemic. Recently, we reported safety, tolerability and …

T cells directed against mutant neo-epitopes drive cancer immunity. However, spontaneous
immune recognition of mutations is inefficient. We recently introduced the concept of …

BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the
SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion conformation, has …

BNT162b2, a lipid nanoparticle (LNP) formulated nucleoside-modified messenger RNA (mRNA)
encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike …

Plasmodium berghei is the causative agent of rodent malaria and is widely used as a model
system to study the liver stage of Plasmodium parasites. The entry of P. berghei sporozoites …

We identify a new noncatalytic growth regime for molecular beam epitaxially grown GaAs
nanowires (NWs) that may provide a route toward axial heterostructures with discrete material …

Background Controlled human malaria infection (CHMI) accelerates development of anti-malarial
interventions. So far, CHMI is done by exposure of volunteers to bites of five …

An effective vaccine is needed to halt the spread of the SARS-CoV-2 pandemic. Recently,
we reported safety, tolerability and antibody response data from an ongoing placebo-…

The rodent malaria parasite Plasmodium berghei develops in hepatocytes within 48–52h
from a single sporozoite into up to 20,000 daughter parasites, so-called merozoites. The …

Background Current artesunate (ARS) regimens for severe malaria are complex. Once daily
intramuscular (im) injection for 3 d would be simpler and more appropriate for remote health …